2m 2m 2m 2m 2m 2m 2m
IMPACT BIO (IBO)
NYSE
$0.46$0.00 (0.00%)
Price as of Jul 14, 2026 4:02 AM EDT- $47.7MMarket Cap
- -24.63%1-Year Change
- BiotechnologyIndustry
IMPACT BIO (IBO)
$0.46$0.00 (0.00%)
IBO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.46 | ||
Change | +$0.02 (+4.75%) | ||
Open | $0.43 | ||
High | $0.49 | ||
Low | $0.43 | ||
Previous Close | $0.44 | ||
Volume | 37,638 | ||
30-Day Average Volume | 68,720 | ||
1-Week Change | -2.94% | ||
1-Month Change | -20.85% | ||
1-Year Change | -24.63% | ||
3-Year Change | -98.14% | ||
5-Year Change | -98.14% | ||
Fundamentals | |||
Shares Outstanding | 107.8M | ||
Total Assets | $17.1M | ||
Market Cap | $47.7M | ||
Enterprise Value | $56.8M | ||
Period: QTR TTM FY | |||
Revenue | $7,000.00 | ||
Net Income | -$2.3M | ||
Free Cash Flow | -$464,000.00 | ||
EBIT | -$2.3M | ||
EBITDA | -$2.0M | ||
Net Working Capital | -$1.3M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | 8,111 | ||
P/B | 4 | ||
P/E | -22 | ||
PEG | 0 | ||
Price/Free Cash Flow | -103 | ||
Price/Operating Cash Flow | -103 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue